PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
22-Feb-2024 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lantronix, Inc. (LTRX) on Behalf of Investors Businesswire
22-Feb-2024 ICON Reports Fourth Quarter and Full Year 2023 Results Businesswire
22-Feb-2024 IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024 Businesswire
22-Feb-2024 Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd. Businesswire
22-Feb-2024 Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate Businesswire
22-Feb-2024 Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results Businesswire
22-Feb-2024 Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update Businesswire
21-Feb-2024 Clinical Review of Pegylated Interferons Suggests Formulation and Mechanism of Action May Improve Outcomes for MPN Patients Businesswire
21-Feb-2024 joimax® Expands Distribution in Italy – Announces New Partnership with Uber Ros S.p.A Businesswire
21-Feb-2024 Over 5 Million Acres of Farmland Globally Use BiOWiSH® Enhanced Fertilizer Businesswire
21-Feb-2024 Bayer Fund Awards More than $12.1M to U.S. Nonprofit Organizations in 2023, Following Latest Round of Grants Totaling $4.7M Businesswire
21-Feb-2024 Insamo Launches with $12M Funding from Playground Global, venBio, and MRL Ventures Fund to Develop Best-in-Class Membrane-Permeable Macrocyclic Peptides Businesswire
21-Feb-2024 jCyte, Inc. Announces Positive Pre-Phase 3 FDA Type B Meeting and Outlines Plans to Start Pivotal Trial of jCell® for Retinitis Pigmentosa in the Second Half of 2024 Businesswire
21-Feb-2024 William S. Marth Joins CONTINUUS Pharmaceuticals Board of Directors, Bringing Commercial Leadership and Manufacturing Expertise to the Company Businesswire
21-Feb-2024 ImmunityBio Announces Full Accrual of First Two Phases of Cancer Vaccine Trial in Participants with Lynch Syndrome and Initiation of Randomized Controlled Phase of the Trial Businesswire
21-Feb-2024 Devonian Announces the Results of its Annual General and Special Shareholders' Meeting, the Approval of Amendments to its Stock Option Plan, and Grant of Stock Options Businesswire
21-Feb-2024 Sunbird Bio to Present Positive Data from APEX Alzheimer’s Disease Diagnostic Platform at AD/PD™ 2024 Businesswire
21-Feb-2024 Coya Therapeutics Issues Letter to Stockholders Highlighting Expansion of COYA 302 into Alzheimer’s Disease and Coya’s Pathway to a “Pipeline in a Product” Businesswire
21-Feb-2024 DNAnexus and Curio Bioscience Announce Collaboration to Streamline and Simplify Data Analysis for Large-Scale Spatial Transcriptomics Projects Businesswire
21-Feb-2024 Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024 Businesswire